As of 2024-12-15, the EV/EBITDA ratio of Oncimmune Holdings PLC (ONC.L) is -27.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ONC.L's latest enterprise value is 21.84 mil GBP. ONC.L's TTM EBITDA according to its financial statements is -0.80 mil GBP. Dividing these 2 quantities gives us the above ONC.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 11.2x | 10.4x |
| Forward P/E multiples | 15.4x - 25.2x | 20.3x |
| Fair Price | (14.90) - (11.92) | (14.86) |
| Upside | -195.2% - -176.2% | -195.0% |
| Date | EV/EBITDA |
| 2024-12-13 | -27.30 |
| 2024-12-12 | -27.30 |
| 2024-12-11 | -27.30 |
| 2024-12-10 | -27.44 |
| 2024-12-09 | -27.09 |
| 2024-12-06 | -27.09 |
| 2024-12-05 | -25.84 |
| 2024-12-04 | -26.89 |
| 2024-12-03 | -26.54 |
| 2024-12-02 | -26.68 |
| 2024-11-29 | -26.05 |
| 2024-11-28 | -26.12 |
| 2024-11-27 | -26.89 |
| 2024-11-26 | -26.89 |
| 2024-11-25 | -26.89 |
| 2024-11-22 | -26.89 |
| 2024-11-21 | -26.61 |
| 2024-11-20 | -26.54 |
| 2024-11-19 | -26.47 |
| 2024-11-18 | -26.19 |
| 2024-11-15 | -27.09 |
| 2024-11-14 | -27.02 |
| 2024-11-13 | -27.02 |
| 2024-11-12 | -27.02 |
| 2024-11-11 | -26.96 |
| 2024-11-08 | -27.09 |
| 2024-11-07 | -26.96 |
| 2024-11-06 | -27.16 |
| 2024-11-05 | -26.89 |
| 2024-11-04 | -26.75 |
| 2024-11-01 | -26.68 |
| 2024-10-31 | -27.09 |
| 2024-10-30 | -27.09 |
| 2024-10-29 | -27.09 |
| 2024-10-28 | -26.75 |
| 2024-10-25 | -25.98 |
| 2024-10-24 | -26.40 |
| 2024-10-23 | -26.05 |
| 2024-10-22 | -26.61 |
| 2024-10-21 | -26.68 |
| 2024-10-18 | -26.89 |
| 2024-10-17 | -24.86 |
| 2024-10-16 | -23.25 |
| 2024-10-15 | -25.21 |
| 2024-10-14 | -27.65 |
| 2024-10-11 | -27.65 |
| 2024-10-10 | -27.58 |
| 2024-10-09 | -27.58 |
| 2024-10-08 | -27.37 |
| 2024-10-07 | -27.58 |